+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 190 Pages
  • October 2020
  • Region: Global
  • GlobalData
  • ID: 5180225
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's Medical Devices sector report, “Peripheral Vascular Stents-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Peripheral Vascular Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A peripheral vascular stent is an expandable perforated tube which is inserted into a peripheral vessel to prevent blood flow constriction.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Peripheral Vascular Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Vascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
2 Introduction
2.1 Peripheral Vascular Stents Overview
3 Products under Development
3.1 Peripheral Vascular Stents-Pipeline Products by Stage of Development
3.2 Peripheral Vascular Stents-Pipeline Products by Segment
3.3 Peripheral Vascular Stents-Pipeline Products by Territory
3.4 Peripheral Vascular Stents-Pipeline Products by Regulatory Path
3.5 Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date
3.6 Peripheral Vascular Stents-Ongoing Clinical Trials
4 Peripheral Vascular Stents-Pipeline Products under Development by Companies
4.1 Peripheral Vascular Stents Companies-Pipeline Products by Stage of Development
4.2 Peripheral Vascular Stents-Pipeline Products by Stage of Development
5 Peripheral Vascular Stents Companies and Product Overview6 Peripheral Vascular Stents-Recent Developments7 Appendix
List of Tables
Table 1: Peripheral Vascular Stents-Pipeline Products by Stage of Development
Table 2: Peripheral Vascular Stents-Pipeline Products by Segment
Table 3: Peripheral Vascular Stents-Pipeline Products by Territory
Table 4: Peripheral Vascular Stents-Pipeline Products by Regulatory Path
Table 5: Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date
Table 6: Peripheral Vascular Stents-Ongoing Clinical Trials
Table 7: Peripheral Vascular Stents Companies-Pipeline Products by Stage of Development
Table 8: Peripheral Vascular Stents-Pipeline Products by Stage of Development
Table 9: 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Bioresorbable Drug Eluting Peripheral Polymer Stent-Product Status
Table 11: Bioresorbable Drug Eluting Peripheral Polymer Stent-Product Description
Table 12: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: ESPRIT Bioresorbable Vascular Scaffold-Product Status
Table 14: ESPRIT Bioresorbable Vascular Scaffold-Product Description
Table 15: ESPRIT BTK Bioresorbable Vascular Scaffold-Product Status
Table 16: ESPRIT BTK Bioresorbable Vascular Scaffold-Product Description
Table 17: Abbott Vascular Inc-Ongoing Clinical Trials Overview
Table 18: ESPRIT BTK Bioresorbable Vascular Scaffold-LIFE-BTK (Pivotal Investigation of Safety and Efficacy of BRS Treatment-below the Knee) Randomized Controlled Trial
Table 19: AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Cre8 BTK-Product Status
Table 21: Cre8 BTK-Product Description
Table 22: Easy Flype-Product Status
Table 23: Easy Flype-Product Description
Table 24: Easy HiFlype-Product Status
Table 25: Easy HiFlype-Product Description
Table 26: Isthmus Logic-Product Status
Table 27: Isthmus Logic-Product Description
Table 28: NiTiDES-Product Status
Table 29: NiTiDES-Product Description
Table 30: AlviMedica Medical Technologies Inc-Ongoing Clinical Trials Overview
Table 31: NiTiDES-Innovative Sirolimus Self Expanding Drug-eluting Stent for the Treatment of Peripheral Disease: Evaluation of Safety and Efficacy. The Illumina Study (Illumina)
Table 32: amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 33: UNITY-B Peripheral Stent-Product Status
Table 34: UNITY-B Peripheral Stent-Product Description
Table 35: AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Pillar Bifurcation Reconstruction Device-Product Status
Table 37: Pillar Bifurcation Reconstruction Device-Product Description
Table 38: Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Bioresorbable Stent-Peripheral Vascular Disease-Product Status
Table 40: Bioresorbable Stent-Peripheral Vascular Disease-Product Description
List of Figures
Figure 1: Peripheral Vascular Stents-Pipeline Products by Stage of Development
Figure 2: Peripheral Vascular Stents-Pipeline Products by Segment
Figure 3: Peripheral Vascular Stents-Pipeline Products by Territory
Figure 4: Peripheral Vascular Stents-Pipeline Products by Regulatory Path
Figure 5: Peripheral Vascular Stents-Pipeline Products by Estimated Approval Date
Figure 6: Peripheral Vascular Stents-Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3D Biotek LLC
  • Abbott Vascular Inc
  • AlviMedica Medical Technologies Inc
  • amg International GmbH
  • AndraTec GmbH
  • Arterius Ltd
  • Boston Scientific Corp
  • Cardiatis SA
  • Cook Medical Inc
  • Cordis Corp
  • Corinnova Inc
  • Efemoral Medical LLC
  • Efferent Labs Inc
  • Electroformed Stents Inc
  • Elixir Medical Corp
  • ID Nest Medical SAS
  • InspireMD Inc
  • Kyoto Medical Planning Co Ltd
  • LimFlow SA
  • Lyra Therapeutics Inc
  • Medtronic Plc
  • Meril Life Sciences Pvt Ltd
  • Micell Technologies Inc
  • Micro Medical Solutions Inc
  • Natec Medical Ltd
  • Nipro Corp
  • NSVascular, Inc.
  • PeriTec Biosciences Ltd
  • QualiMed Innovative Medizinprodukte GmbH
  • Qvanteq AG
  • Reflow Medical, Inc.
  • Synergy Flow Ltd
  • Taewoong Medical Co Ltd
  • Tepha Inc
  • TissueGen Inc
  • Tractivus SL
  • University of Michigan
  • University of Pittsburgh Medical Center
  • Vascular Bioresorbable Technologies
  • Vascular Concepts Ltd
  • Vascular Dynamics Ltd.
  • Vesper Medical Inc
  • Wake Forest University Health Sciences
  • Xenogenics Corporation
  • Zhejiang Zylox Medical Device Co Ltd
  • Zorion Medical